An electrophysiology study involves placing electrode catheters in the heart to assess conduction and induce arrhythmias. It can evaluate conditions like supraventricular tachycardia, ventricular tachycardia, sinus node dysfunction, and conduction abnormalities. The study assesses basic intervals, sinus node function, refractory periods, and the response to atrial and ventricular extra stimuli pacing to determine appropriate therapy. Complications may include vascular or cardiac issues, but the study provides important information to guide treatment of arrhythmias.
Speckle tracking echocardiography (STE) is an echocardiographic imaging technique that analyzes the motion of tissues in the heart by using the naturally occurring speckle pattern in the myocardium or blood when imaged by ultrasound.
Our concepts of heart disease are based on the enormous reservoir of physiologic and anatomic knowledge derived from the past 70 years' of experience in the cardiac catheterization laboratory.
As Andre Cournand remarked in his Nobel lecture of December 11, 1956, the cardiac catheter was the key in the lock.
By turning this key, Cournand and his colleagues led us into a new era in the understanding of normal and disordered cardiac function in huma
Based on the principle that the distal coronary pressure measured during vasodilation is directly proportional to maximum vasodilated perfusion.
FFR is defined as the ratio of maximum blood flow in a stenotic artery to maximum blood flow in the same artery if there were no stenosis.
FFR is simply calculated as a ratio of mean pressure distal to a stenosis (Pd) to the mean pressure proximal stenosis, that is the mean pressure in the aorta (Pa), during maximal hyperaemia.
Speckle tracking echocardiography (STE) is an echocardiographic imaging technique that analyzes the motion of tissues in the heart by using the naturally occurring speckle pattern in the myocardium or blood when imaged by ultrasound.
Our concepts of heart disease are based on the enormous reservoir of physiologic and anatomic knowledge derived from the past 70 years' of experience in the cardiac catheterization laboratory.
As Andre Cournand remarked in his Nobel lecture of December 11, 1956, the cardiac catheter was the key in the lock.
By turning this key, Cournand and his colleagues led us into a new era in the understanding of normal and disordered cardiac function in huma
Based on the principle that the distal coronary pressure measured during vasodilation is directly proportional to maximum vasodilated perfusion.
FFR is defined as the ratio of maximum blood flow in a stenotic artery to maximum blood flow in the same artery if there were no stenosis.
FFR is simply calculated as a ratio of mean pressure distal to a stenosis (Pd) to the mean pressure proximal stenosis, that is the mean pressure in the aorta (Pa), during maximal hyperaemia.
There are many interventional cardiac procedure those need a trans septal puncture of the interatrial septum. This presentation clearly elaborates everything you need to know about the TSP.
A lecture on the echocardiographic evaluation of hypertrophic cardiomyopathy. Starts with an overview of the topic then a systematic approach to diagnosis and then a differential diagnosis followed by take-home messages and conclusion.
There are many interventional cardiac procedure those need a trans septal puncture of the interatrial septum. This presentation clearly elaborates everything you need to know about the TSP.
A lecture on the echocardiographic evaluation of hypertrophic cardiomyopathy. Starts with an overview of the topic then a systematic approach to diagnosis and then a differential diagnosis followed by take-home messages and conclusion.
An electrocardiogram (ECG or EKG) records the electrical signal from your heart to check for different heart conditions. Electrodes are placed on your chest to record your heart's electrical signals, which cause your heart to beat. The signals are shown as waves on an attached computer monitor or printer
AV nodal reentrant tachycardia (AVNRT), or atrioventricular nodal reentrant tachycardia, is a type of tachycardia (fast rhythm) of the heart. It is a type of supraventricular tachycardia (SVT), meaning that it originates from a location within the heart above the bundle of His. AV nodal reentrant tachycardia is the most common regular supraventricular tachycardia. It is more common in women than men (approximately 75% of cases occur in females). The main symptom is palpitations. Treatment may be with specific physical maneuvers, medication, or, rarely, synchronized cardioversion. Frequent attacks may require radiofrequency ablation, in which the abnormally conducting tissue in the heart is destroyed.
AVNRT occurs when a reentry circuit forms within or just next to the atrioventricular node. The circuit usually involves two anatomical pathways: the fast pathway and the slow pathway, which are both in the right atrium. The slow pathway (which is usually targeted for ablation) is located inferior and slightly posterior to the AV node, often following the anterior margin of the coronary sinus. The fast pathway is usually located just superior and posterior to the AV node. These pathways are formed from tissue that behaves very much like the AV node, and some authors regard them as part of the AV node.
The fast and slow pathways should not be confused with the accessory pathways that give rise to Wolff-Parkinson-White syndrome (WPW syndrome) or atrioventricular reciprocating tachycardia (AVRT). In AVNRT, the fast and slow pathways are located within the right atrium close to or within the AV node and exhibit electrophysiologic properties similar to AV nodal tissue. Accessory pathways that give rise to WPW syndrome and AVRT are located in the atrioventricular valvular rings. They provide a direct connection between the atria and ventricles, and have electrophysiologic properties similar to ventricular myocardium.
Presentation on basic principles of pediatric ecg with important examples: BY Dr. Nivedita Mishra (PGY2 PEDIATRICS, TRIBHUVAN UNIVERSITY TEACHING HOSPITAL,KATHMANDU,NEPAL)
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. Definition & Indications
• Electrophysiology study (EPS) involves the placement of multipolar electrode
catheters in specific locations in the heart in order to:
• Assess the conduction system of the heart, including SA node, AV node and HPS
• Determine the location and characteristics of arrhythmias and the type of therapy required
• Evaluate the efficacy of therapies involving antiarrhythmic drugs and devices.
• Indications:
• Supraventricular tachycardia (SVT): Narrow QRS complex SVT, Wide QRS complex SVT
• Ventricular tachycardia (VT): Non-sustained VT, Sustained monomorphic VT, Polymorphic VT,
PVC
• Sinus node dysfunction: Sinus bradycardia, Sinoatrial block, Sinus arrest, Chronotropic
incompetence, Sinus pause.
• Conduction abnormalities: AV block, Bundle branch block/bi-, tri- fascicular block,
intraventricular conduction disease
• Evaluation of syncope: the most common indication of EPS; may be caused by AV block or
SND
• Other indications
3. Patient Preparations
• Informed consent:
• Vascular complications: bruising with palpable hematomas, venous
thrombosis, arterial occlusion, formation of fistulae or false aneurysm
• Major but treatable conditions: pneumothorax, cardiac tamponade
• Specific complications: AV nodal damage, arrhythmia induction
• Thromboembolic complications
• Radiation exposure
• Patient preparations:
• Antiarrhythmic drugs should be discontinued for at least four half lives (2-3
days)
• Fasting at least 6 hours, and usually overnight
• IV access and 12-leads ECG should be obtained before procedure
6. Minimum Protocol for Diagnostic EPS
• Basic intervals
• Measurement: rhythm, cycle length (CL), PA
int., AH int., HV int., QRS dur. & morph., QTc
int.
• SA node function
• Assessment of SNRT at basic CLs of 800, 600,
500, 400 and 350 ms
• Measurement: CSRNT
• Atrial extra stimulus pacing
• Assessment of refractoriness at CLs of 600 and
400 ms
• Measurements: AVN ERP, AVN FRP, AERP
• It can also assess dual AV nodal physiology,
ventricular pre-excitation dan may induce
atrial arrhythmia
• Atrial incremental pacing
• Incremental atrial pacing from slightly faster
than sinus rhythm down to AV Wenckebach
point, or a minimum CL of 300 ms
• Measurement: AV WCL
• Ventricular extra stimulus pacing
• Assessment of refractoriness at CLs of 600 and
400 ms
• Measurement: VERP, retrograde AVN ERP
• It can also assess retrograde conduction and
atrial activation and may induce VT
• Ventricular incremental pacing
• Incremental atrial pacing from slightly faster
than sinus rhythm down to VA Wenckebach
point, or a minimum CL of 300 ms
• Measurement: VA WCL (only if VA
conduction is present)
7. Variations on the Minimum Protocols
• Suspected sinus node disease
• Measurement of SACT
• Suspected ventricular tachycardia
• Programmed ventricular stimulation
using multiple extra stimuli (short-
long-short induction sequences)
• Suspected AV nodal reentry or
atrial arrhythmias
• Intravenous isoproterenol and/or
atropine
• Atrial extra stimulus testing at
different cycle lengths, using double,
triple or more atrial extra stimuli
• Suspected accessory pathway
• Intravenous isoproterenol and/or
atropine may facilitate tachycardia
induction, usually by improving
conduction over the AVN
• Pacing at sites other than HRA or RVA
may demonstrate the presence of APs
• Pacing and drug administration
during tachycardia
14. Refractory Periods: ERP, RRP, FRP
• The refractoriness of a cardiac
tissue can be defined by the
response of that tissue to the
introduction of premature
stimuli.
• Refractoriness is generally
expressed in terms of three
measurements
• Effective refractory period
(ERP)
• Relative refractory period
(RRP)
• Functional refractory period
(FRP)
15.
16.
17.
18. Antegrade & Retrograde Refractory Periods
ERP of the atrium: the longest S1-S2 interval that fails to
result in atrial depolarization
ERP of the AVN: the longest A1-A2 interval measured in
the His bundle electrogram that fails to propagate to the
His bundle
ERP of the HPS: the longest H1-H2 interval that fails to
result in ventricular depolarization
RRP of the atrium: the longest S1-S2 interval at which the
S2-A2 interval exceeds the S1-A1 interval (latency)
RRP of the AVN: the longest A1-A2 interval at which the
A2-H2 interval exceeds the A1-H1 interval
RRP of the HPS: the longest H1-H2 interval at which the
H2-V2 interval exceeds the H1-V1 interval or results in an
aberrant QRS complex
FRP of the atrium: the shortest A1-A2 interval in response
to any S1-S2 interval
FRP of the AV node: the shortest H1-H2 interval in
response to any A1-A2 interval
FRP of the HPS: the shortest V1-V2 interval in response to
any H1-H2 interval
ERP of the ventricle: the longest S1-S2 interval that fails
to evoke a ventricular response
ERP of the HPS: the longest S1-S2 or V1-V2 interval at
which S2 or V2 blocks below the bundle of His.
ERP of the AVN: the longest S1-H2 or H1-H2 interval at
which H2 fails to propagate to the atrium
RRP of the ventricle: the longest S1-S2 interval at which
the S2-V2 interval exceeds the S1-V1 interval.
FRP of the ventricle: the shortest V1-V2 interval as
measured on the surface ECG or local ventricular
electrogram in response to any S1-S2 interval
FRP of the HPS: the shortest S1-H2 or H1-H2 interval in
response to any V1-V2 interval
FRP of the AVN: the shortest A1-A2 interval in response to
any H1-H2 interval
Antegrade Refractory Periods Retrograde Refractory Periods
20. Atrial Extra Stimulus Pacing: Dual AV nodal physiology
• Dual or multiple AV nodal pathways can be
demonstrated in 7% of the population.
• Fast pathway is associated with rapid conduction (short AH
interval) and a long refractory period.
• Slow pathway is associated with a slow conduction (long AH
interval) and a shorter refractory period.
• Conduction switches (“jump”) to the slow pathway
when the fast pathway reaches its refractory period.
• With the introduction of premature atrial stimuli, a jump
from the fast to the slow pathway is defined by a ≥50 msec
increase in the A2-H2 interval in response to a 10 msec
decrease in the A1-A2 coupling interval
Other indications for EPS include patients with progressive cardiac conduction disease, dilated cardiomyopathy, muscular dystrophies (Duchenne, Becker), post antiarrhythmic surgery, sarcoidosis, congenital heart disease, survivors of cardiac arrest, undocumented palpitations, guiding drug therapy, conduction disorders after transcatheter aortic valve replacement.
Catheters with multiple (4 to 64) platinum electrodes through which electrical stimuli can be delivered and intracardiac electrograms recorded are advanced through one or more veins (typically the inferior vena cava [IVC] or superior vena cava [SVC]) for mapping RA, RV, LA and LV; or retrogradely through the aorta (transaortic approach) for mapping the LV and mitral annulus (for VT and left-sided BTs); or transeptal approach for mapping and ablation in the LA and has also been increasingly used for accessing the LV..
During a basic diagnostic EP study, catheters are placed in the right atrium (usually right atrial appendage [RAA]), across the tricuspid annulus to record a His bundle electrogram, in the coronary sinus (CS), and in the right ventricle. HRA - SA node (near junction of SVC)
His - for recording and marking AV node
CS - for recording/pacing; records left atrial activity and activity from the base of the left ventricle.
RVA - for recording/pacing
Measurement of basic intervals establishes whether a long PR interval is due to slow conduction in the AVN or HPS (or both), and may indicate whether a short PR interval is due to ventricular pre-excitation
Atrial extra stimulus pacing can also assess dual AV nodal physiology, ventricular pre-excitation dan atrial arrhythmia induction.
Eccentric retrograde atrial activation or VA conduction that is non-decremental or shows discontinuity may indicate the presence of an accessory pathway or dual AV nodal physiology.
Baseline recordings obtained during a typical electrophysiological study include surface electrocardiograms to time events from the body's surface, and intra-cardiac electrograms, all of which are recorded simultaneously.
The intracardiac recordings obtained from the electrodes are sharper unlike the waveforms of the surface ECG. Typical electrograms of the high right atrium electrode will show a sharp deflection in the early part of the P wave. Recording from the His electrode shows an A (Atrial) signal, a H (His) signal and a V (Ventricular) signal. As the coronary sinus is in the left AV groove, a coronary sinus catheter records both the left atrial and left ventricular electrograms. Activation of the left atrium at the CS ostium (CSP) electrode is normally earlier than at the CS distal (CSD) electrode. RV catheter records ventricular signals from the right ventricle.
Pacing rate or heart rate (beats per minute) = 60,000/cycle length (msec)
QRS complex indicates the duration of ventricular activation. QT interval represents the combination of ventricular activation and repolarization, it depends on HR. QTc can be calculated using Bazett or Frederica formula.
The specific intervals measured during sinus rhythm are:
1. PA interval: time for activation to travel into the right atrium between the region of the sinus node and the region of the atrioventricular node. This PA interval is measured between the earliest recorded atrial activity in any channel (either the P-wave onset, or that of the earliest atrial electrogram) and the rapid deflection of the atrial electrogram on the His bundle catheter. The standard value is considered 25-55 ms. A prolonged PA interval indicates delay in intra-atrial conduction, usually due to atrial disease or drugs.
2. AH interval: time for activation to travel over the AVN; is measured between atrial electrogram recorded on His bundle catheter and the beginning of the His electrogram itself. The normal value is 55-125 ms. Causes of prolonged AH interval: increased vagal tone (prolonged AH interval in well sedated patient use atropine to confirm), decreased cycle length (due to its decremental conduction properties related to Ca2+ phase 0 depolarization in AVN), infectious processes such as Lyme disease, antiarrhythmic medications, infarction (inferior myocardial infarction [MI]), or fibrocalcific degeneration. Causes of shortened AH interval: heightened sympathetic tone, conduction over a fast pathway in an individual with dual AV nodal pathways, a bypass tract (BT) between the atrium and His bundle (i.e., atrio-His bypass tract/James fiber).
3. HBE duration: the duration from the beginning to the last component of the His bundle electrogram. It corresponds to the total conduction time through the His Bundle. The standard value is under 30 ms. Conduction delay in His bundle manifests as a notched/fragmented deflection or split HBE with separated early and late components.
4. HV interval: the conduction time over the specialized ventricular conduction system, His-Purkinje system (HPS); it gets measured between the His bundle electrogram and the earliest ventricular activation. The standard value is 35-55 ms. It is not affected with autonomic tone or varied cycle length [HPS does not have decremental conduction properties (due to Na+ dependent phase 0 depolarization)]. Causes of prolonged HV interval: degenerative fibrocalcific disease (Lyme disease, aortic & mitral annular calcification), infiltrative processes, surgery or antiarrhythmic drugs. Causes of shortened HV interval: a bypass tract (BT) between the atrium and ventricle (i.e., atrio-ventricular bypass tract/Bundle of Kent), PVC (a fusion between supraventricular and ventricular impulse).
Two tests of sinus node function are in common use: the sinus node recovery time (SNRT) & the sino-atrial conduction time (SACT)
SNRT is a measure of the recovery of sinus node automaticity following overdrive suppression. The test is performed by pacing the atrium for at least 1 minute (or 30s) at multiple cycle lengths above the intrinsic sinus rate (basic CLs of 800, 600, 500, 400 and 350 ms). The sinus node is suppressed, and once pacing is stopped, the time required for sinus node automaticity to recover is measured. This is the most widely used electrophysiologic measure of sinus node function because it has correlated best with clinical evidence of sinus node dysfunction. The longest values of SNRT and CSNRT obtained are used. Normal values: maximum SNRT <1500 ms and maximum SNRT <550 ms (500-600 ms). However, SNRT varies with the sinus rate, so CNSRT is used. CSNRT = SNRT – SCL (Sinus cycle length).
Figure 2.2. The sinus recovery time (SNRT) is the time taken for sinus rhythm (yellow) to resume after a period (conventionally 30s) of overdrive atrial pacing (blue).
Four possibilities of atrial extrastimulus pacing to SA node:
(i) No reset: a late coupled atrial extrastimulus (long A1A2) collides with a sinus impulse outside the SA node, and does not affect the timing of the next sinus beat (A3). Thus, the return cycle length (A2A3) is a full compensatory pause, such that A1A2 + A2A3 = 2 x A1A1 (SCL)
(ii) Reset: an earlier coupled atrial extrastimulus (shorter A1A2) and resets the SA node. The next sinus beat originates one SCL later, and is conducted out to the atrium. Thus, A1A2 + A2A3 < 2x A1A1 and A2A3 = A1A1 + 2 x SACT. Therefore, SACT can be calculated (Reset is a must!)
(iii) Interpolation: if its conduction into SA node is blocked, the SA node is not reset, and the next sinus impulse emerges on time. This extrastimulus is said to “interpolated” between sinus beats. Thus, A1A2 + A2A3 ~ A1A1
(iv) Echo: The extrastimulus may give rise to local “reentry”, resulting in a very premature A3. Thus, A1A2 + A2A3 < A1A1
SACT is a test of sinus node function, which is performed with the introduction of premature atrial stimuli during sinus rhythm following an 8- to 10-beat stable drive train at a cycle length just shorter than sinus. This test assumes that the time required to enter the sinus node is equal to the conduction time out of the sinus node and back to the recording/stimulating catheter (may not be true). It is calculated by subtracting the baseline SCL or A1-A1 from the time it takes for the sinus node to recover from the premature stimulus (A2-A3) divided by two for the time in and out of the sinus node.
SACT = [(A2−A3)−(A1−A1)]/2. Normal SACT value is between 50-115 ms
“Reset” and “No Reset” criteria:
(i) No reset: A1A2 + A2A3 = 2 x A1A1
(ii) Reset: A1A2 + A2A3 < 2x A1A1
The refractoriness of a cardiac tissue can be defined by the response of that tissue to the introduction of premature stimuli. In clinical electrophysiology, refractoriness is generally expressed in terms of three measurements: effective, relative and functional. The refractory periods of the cardiac chambers and the components of the AV conduction system are evaluated by the technique of premature stimulation. Refractoriness is influenced by several factors including the intensity of the extrastimuli and the cycle length of the spontaneous or paced rate at which the refractory period is measured. There is a basic difference in the responses of myocardium and nodal tissue to increasing rate or increasing prematurity: in atrial or ventricular muscle there is a decrease in the refractory periods, in contrast to the AV node where there is an increase in refractory intervals and conduction time (decremental conduction).
Refractory periods:
1. Effective refractory period (ERP) of a cardiac tissue is the longest coupling interval between the basic drive and the premature impulse that fails to propagate/be conducted through that tissue. The effective refractory period (ERP) of a tissue or structure is the longest coupling interval that fails to capture the tissue or be conducted over the structure.
2. Relative refractory period (RRP) is the longest coupling interval of a premature impulse that results in prolonged conduction of the premature impulse relative to that of the basic drive. The relative refractory period (RRP) is the ‘input’ interval to a tissue or structure at which the ‘output’ interval just begins to differ from the ‘input’ interval.
3. Functional refractory period (FRP) of a cardiac tissue is the minimum interval between two consecutively conducted impulses through that tissue. The functional refractory period (FRP) of a tissue or structure is the shortest ‘output’ coupling interval that can be elicited from a tissue or structure by any ‘input’ interval.
By convention, the notation used is as follows: S1 is the basic stimulus and S2 is the first premature stimulus; S1-S1 is the paced cycle length; S1 –S2 is the coupling interval between the last complex of the paced cycle and the premature stimulus S2. The corresponding notations for the atrial, His-bundle, and ventricular electrograms are A1-A1 and A1-A2, H1-H1 and H1-H2, and V1-V1 and V1-V2, respectively.
Decremental conduction of AVN is due Ca2+ dependent phase 0 depolarization (L-type Ca2+ ion channel is voltage-operated; activated by depolarization. Long-lasting activation. Inactivation is time-dependent and Ca2+-dependent).
In patients with dual AV nodal pathways, conduction in the basal state occurs over the fast pathway in most circumstances (short or normal PR interval). Conduction switches to the slow pathway when the refractory period of the fast pathway is reached and a “jump” to the slow pathway results.
Patient with a posteroseptal accessory pathway. During drive train (S1S1), there is pre-excitation with a slurred upstroke of the QRS complex. With the extrastimulus (S2), a greater degree of pre-excitation is seen due to delayed conduction of the AV node (Increased AH interval). Note that, stimulus-to-delta interval is unchanged.
Wenckebach CL (WCL) is the cycle length at which 1:1 conduction over the AV node ceases.
At CL 340 ms, there is prolongation of AH interval followed by a blocked cycle (*). Therefore AV WCL is 340 ms
VERP and retrograde AVN ERP can be calculated
Latency is a delay occur between the extrastimulus and the electrogram generated by the tissue because the extrastimulus is impinging on the refractory period of the adjacent myocardium.
VERP and retrograde AVN ERP can be calculated
Latency is a delay occur between the extrastimulus and the electrogram generated by the tissue because the extrastimulus is impinging on the refractory period of the adjacent myocardium.
VERP and retrograde AVN ERP can be calculated
Latency is a delay occur between the extrastimulus and the electrogram generated by the tissue because the extrastimulus is impinging on the refractory period of the adjacent myocardium.
VERP and retrograde AVN ERP can be calculated
Latency is a delay occur between the extrastimulus and the electrogram generated by the tissue because the extrastimulus is impinging on the refractory period of the adjacent myocardium.
During ventricular pacing atrial activation pattern whether central (His A is earliest) or eccentric (His A is later that A in either RA or LA recording catheter) is seen. Central and decremental conduction generally suggests conduction through the nodal tissue (Figure 5a). Eccentric and non-decremental conduction suggests presence of a retrograde conducting accessory pathway (Figure 5c).
At CL 320 ms, there is 1:1 VA conduction. However, at CL 300 ms there is intermittent VA block (*). Therefore, VA WCL is 300 ms